{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06173401",
            "orgStudyIdInfo": {
                "id": "IRB-72248"
            },
            "secondaryIdInfos": [
                {
                    "id": "BRN0060",
                    "type": "OTHER",
                    "domain": "OnCore number"
                }
            ],
            "organization": {
                "fullName": "Stanford University",
                "class": "OTHER"
            },
            "briefTitle": "Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases",
            "officialTitle": "A Randomized Phase III TriaL Comparing SingLe- Versus Multi-Fraction Spine STereotActic Radiosurgery for Patients With Spinal Metastases (ALL-STAR)",
            "therapeuticArea": [
                "Other"
            ],
            "study": "comparing-single-vs-multi-fraction-spine-stereotactic-radiosurgery-in-spinal-metastases"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-12-18",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2028-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-11-28",
            "studyFirstSubmitQcDate": "2023-12-07",
            "studyFirstPostDateStruct": {
                "date": "2023-12-15",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-02",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Stanford University",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "The goal of this study is to determine whether fractionated Stereotactic radiosurgery (SRS) for spine metastases is associated with improved local tumor control compared to single-fraction SRS. Patients will be randomized to treatment with spine SRS using either 22 Gy in 1 fraction or 28 Gy in 2 fractions."
        },
        "conditionsModule": {
            "conditions": [
                "Spinal Metastases"
            ],
            "keywords": [
                "spine stereotactic radiosurgery",
                "cervical",
                "lumbar",
                "thoracic",
                "metastases"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 274,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Single-fraction spine SRS",
                    "type": "EXPERIMENTAL",
                    "description": "Single-fraction spine SRS (22 Gy x 1)",
                    "interventionNames": [
                        "Radiation: Single-fraction spine SRS"
                    ]
                },
                {
                    "label": "Multi-fraction spine SRS",
                    "type": "EXPERIMENTAL",
                    "description": "Multi-fraction spine SRS (14 Gy x 2)",
                    "interventionNames": [
                        "Radiation: Multi-fraction spine SRS"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "RADIATION",
                    "name": "Single-fraction spine SRS",
                    "description": "Treatment Arm 1: Single-fraction spine SRS (22 Gy x 1)",
                    "armGroupLabels": [
                        "Single-fraction spine SRS"
                    ]
                },
                {
                    "type": "RADIATION",
                    "name": "Multi-fraction spine SRS",
                    "description": "Treatment Arm 2: Multi-fraction spine SRS (14 Gy x 2)",
                    "armGroupLabels": [
                        "Multi-fraction spine SRS"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Tumor control",
                    "description": "To determine whether fractionated Stereotactic Radiosurgery (SRS) for spine metastases is associated with improved local tumor control at 1 year following SRS compared to single-fraction SRS.",
                    "timeFrame": "1 year"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Euro-QOL EQ-5D-3L health-related quality of life questionnaire",
                    "description": "To compare health-related quality of life (EQ-5D-3L) following SRS and assess patient-reported health related quality of life pertaining to mobility, self-care, usual activities, pain, and anxiety.",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 health-related quality of life scale score",
                    "description": "To compare health-related quality of life (EORTC QLQ-C30) following SRS and assess patient-reported health related quality of life pertaining to overall health and quality of daily life.",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "EORTC QLQ-BM22 health-related quality of life questionnaire",
                    "description": "To compare health-related quality of life (EORTC QLQ-BM22) following SRS and assess patient-reported health related quality of life pertaining to pain associated with performing activities of daily life.",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Pain Score",
                    "description": "Pain associated with the treated area will be assessed by asking patients to rate their pain on a 0-10 scale (\"no pain\" to \"pain as bad as you can imagine\")",
                    "timeFrame": "1-2 weeks after SRS and 1, 3, 6, 12, 18, and 24 months following SRS"
                },
                {
                    "measure": "Medication Intake",
                    "description": "Collect medications taken within the last 24 hours.",
                    "timeFrame": "1-2 weeks after SRS and 1, 3, 6, 12, 18, and 24 months following SRS"
                },
                {
                    "measure": "Number of participants with CTCAE grade grade 2 or higher adverse effects",
                    "description": "To determine 1-year rate CTCAE grade 2 or higher adverse effects, following SRS",
                    "timeFrame": "1 year"
                },
                {
                    "measure": "Rate of vertebral compression fracture",
                    "description": "To determine 1-year rate of vertebral compression fracture (VCF), following SRS",
                    "timeFrame": "1 year"
                },
                {
                    "measure": "Rate of local failure",
                    "description": "To determine 2-year rate of local failure following SRS",
                    "timeFrame": "2 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically, cytologically, or radiographically confirmed diagnosis of metastatic cancer Age \u2265 18 years\n* Patients who have cervical, thoracic, or lumbar spine metastasis that need treatment.\n* Patients will have 1 to 3 separate spinal sites that require treatment.\n* Each spinal site to be treated on trial will span 1-2 contiguous vertebral levels\n* ECOG 0-2\n* Negative serum or urine pregnancy test within 14 days prior to enrollment for women of childbearing potential or who are not postmenopausal\n* Women of childbearing potential and male participants who are sexually active must agree to use a medically effective means of birth control\n* Ability to understand and the willingness to sign (personally or by a legal authorized representative) the written IRB approved informed consent document\n\nExclusion Criteria:\n\n* Prior or planned radiation off study within or overlapping with study treatment site\n* Inability to have either an MRI or a CT scan. Patients with pacemaker will be allowed to undergo CT instead of MRI\n* Pediatric patients (age \\<18 years old), pregnant women, and nursing patients will be excluded\n* Histology's of myeloma or lymphoma\n* Patients with strength 1-3 (of 5), bladder incontinence, bowel incontinence, and/or bladder retention that is associated with spinal site to be treated\n* Prior surgery to spinal site intended to be treated with protocol SRS\n* Excluded those with SINS 13-18",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Jillian Skerchak",
                    "role": "CONTACT",
                    "phone": "650-721-4072",
                    "email": "jskerch1@stanford.edu"
                },
                {
                    "name": "Kelly Huang",
                    "role": "CONTACT",
                    "phone": "650-724-4606",
                    "email": "kelhuang@stanford.edu"
                }
            ],
            "locations": [
                {
                    "facility": "Stanford University School of Medicine",
                    "status": "RECRUITING",
                    "city": "Palo Alto",
                    "state": "California",
                    "zip": "94305",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jillian Skerchak",
                            "role": "CONTACT",
                            "phone": "650-721-4072",
                            "email": "jskerch1@stanford.edu"
                        },
                        {
                            "name": "Erqi L Pollom, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.44188,
                        "lon": -122.14302
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009362",
                    "term": "Neoplasm Metastasis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009385",
                    "term": "Neoplastic Processes"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12307",
                    "name": "Neoplasm Metastasis",
                    "asFound": "Metastases",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12330",
                    "name": "Neoplastic Processes",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}